NO20071143L - Rekombinante vaksiner mot caligid copepoder (sjolus) og antigene sekvenser av disse - Google Patents

Rekombinante vaksiner mot caligid copepoder (sjolus) og antigene sekvenser av disse

Info

Publication number
NO20071143L
NO20071143L NO20071143A NO20071143A NO20071143L NO 20071143 L NO20071143 L NO 20071143L NO 20071143 A NO20071143 A NO 20071143A NO 20071143 A NO20071143 A NO 20071143A NO 20071143 L NO20071143 L NO 20071143L
Authority
NO
Norway
Prior art keywords
sjolus
vaccines against
recombinant vaccines
antigenic sequences
caligid copepods
Prior art date
Application number
NO20071143A
Other languages
English (en)
Other versions
NO342565B1 (no
Inventor
Neil W Ross
Stewart C Johnson
Mark D Fast
Kathryn Vanya Ewart
Original Assignee
Ca Nat Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ca Nat Research Council filed Critical Ca Nat Research Council
Publication of NO20071143L publication Critical patent/NO20071143L/no
Publication of NO342565B1 publication Critical patent/NO342565B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43509—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from crustaceans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
    • Y02A40/81—Aquaculture, e.g. of fish

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Insects & Arthropods (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

Molekylære mål og vaksiner mot dem i behandling av fiskelus er skaffet til veie, særlig caligid kopepoder. Vaksiner målrettet mot L. salmonis trypsin er vist å redusere mengden av fiskelus som er til stede i immunutfordret laks fiia dag 14 p. i. og fremover. Ytterligere og nye molekylære mål for vaksiner blir også skaffet til veie.
NO20071143A 2004-07-28 2007-02-28 Rekombinante vaksiner mot caligid copepoder (sjølus) og antigene sekvenser av disse. NO342565B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59162604P 2004-07-28 2004-07-28
PCT/CA2005/001178 WO2006010265A1 (en) 2004-07-28 2005-07-28 Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof

Publications (2)

Publication Number Publication Date
NO20071143L true NO20071143L (no) 2007-02-28
NO342565B1 NO342565B1 (no) 2018-06-18

Family

ID=35785878

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071143A NO342565B1 (no) 2004-07-28 2007-02-28 Rekombinante vaksiner mot caligid copepoder (sjølus) og antigene sekvenser av disse.

Country Status (10)

Country Link
US (1) US8207132B2 (no)
EP (8) EP2405003B1 (no)
CA (1) CA2575218C (no)
CL (1) CL2011002334A1 (no)
DK (2) DK2397553T3 (no)
ES (2) ES2575156T3 (no)
NO (1) NO342565B1 (no)
PL (1) PL2397553T3 (no)
PT (1) PT2397553E (no)
WO (1) WO2006010265A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200801034A (en) * 2005-10-05 2008-01-01 Intervet Int Bv Novel sea lice vaccine
WO2007146359A2 (en) * 2006-06-14 2007-12-21 Diversa Corporation Sea lice antigen vaccines
CU23634A1 (es) 2007-05-31 2011-02-24 Ct Ingenieria Genetica Biotech Secuencias de ácido nucleico y aminoácidos, y vacuna para el control de infestaciones por ectoparásitos en peces
WO2009067020A1 (en) 2007-11-19 2009-05-28 Calanus As Bioactive copepod-compositions, processes for the production thereof, and use thereof to prevent or treat hosts infested by phylogenetically similar ectoparasites
CA2873599A1 (en) * 2012-05-17 2013-11-21 Tecnovax Chile S.A. Peptides inducing an immune response against copepods and/or the development of a mucous shield in fish; vaccines, uses and methods for modulating the fish immune response and/or for inducing development of a mucous shield in fish
NO343281B1 (en) * 2016-12-30 2019-01-14 Aqua Health As Peptides for the inhibition of trypsin and sea lice infestation.
WO2017213521A1 (en) * 2016-06-10 2017-12-14 Aqua Health As Peptides for the inhibition of trypsin
NO343723B1 (en) * 2016-06-10 2019-05-20 Aqua Health As Peptides for the inhibition of trypsin and sea lice infestation.
CA3088092A1 (en) 2018-01-25 2019-08-01 Benchmark Animal Health Limited Sea lice antigens and vaccines
GB201902425D0 (en) 2019-02-22 2019-04-10 Benchmark Animal Health Ltd Sea lice antigens and vaccines
EP3920964A1 (en) * 2019-02-04 2021-12-15 Benchmark Animal Health Limited Sea lice vaccines

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0332660A4 (en) * 1986-11-24 1990-12-05 Genex Corporation Bioadhesives
EP0725838A4 (en) 1993-10-26 1997-02-26 United Biomedical Inc STRUCTURED SYNTHETIC ANTIGAN BANKS AS DIAGNOSTICS, VACCINE AND THERAPEUTIC AGENTS
JPH07163361A (ja) 1993-12-14 1995-06-27 Kaiyo Bio Technol Kenkyusho:Kk ムラサキイガイ接着蛋白質遺伝子
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof
US20020013955A1 (en) * 1998-06-10 2002-01-31 Sharon Ogden Production of recombinant protein in transgenic fish
WO2003101482A2 (en) 2002-05-31 2003-12-11 Genesis Group Inc. Liposome vaccine formulations for fin-fish
GB0513484D0 (en) 2005-07-01 2005-08-10 Accentus Plc Producing liquid hydrocarbons
TW200801034A (en) * 2005-10-05 2008-01-01 Intervet Int Bv Novel sea lice vaccine

Also Published As

Publication number Publication date
EP2407542A1 (en) 2012-01-18
ES2548677T3 (es) 2015-10-20
EP2405003A1 (en) 2012-01-11
US20080003233A1 (en) 2008-01-03
EP2397552A1 (en) 2011-12-21
WO2006010265A1 (en) 2006-02-02
EP2405004A1 (en) 2012-01-11
EP2397553A1 (en) 2011-12-21
CA2575218A1 (en) 2006-02-02
ES2575156T3 (es) 2016-06-24
CA2575218C (en) 2013-07-09
CL2011002334A1 (es) 2012-03-30
EP2397553B1 (en) 2016-05-04
DK2405003T3 (en) 2015-09-21
EP2410055A1 (en) 2012-01-25
DK2397553T3 (en) 2016-06-13
PT2397553E (pt) 2016-06-08
PL2397553T3 (pl) 2017-03-31
EP2402445A1 (en) 2012-01-04
EP2405003B1 (en) 2015-09-02
EP1789554A1 (en) 2007-05-30
NO342565B1 (no) 2018-06-18
US8207132B2 (en) 2012-06-26
EP1789554B1 (en) 2018-07-04
EP1789554A4 (en) 2009-05-06

Similar Documents

Publication Publication Date Title
Dunbar et al. Fireside chat: the impact of fire on hominin socioecology
NO20064781L (no) Fremgangsmater og adjuvanser for a forbedre immunresponser mot vaksiner og fremgangsmater for anvendelse
NO20060416L (no) Ny anvendelse I
BR0316758A (pt) Vacinas baseadas em levedura como imunoterapia
MX2008013993A (es) Combinación adyuvante sinergistica de anticuerpo agonista de cd40/interferona tipo 1, conjugados que la contienen y uso de los mismos como un terapeutico para aumentar la inmunidad celular.
WO2004069190A3 (en) Combination therapy for treating protein deficiency disorders
NO20015073D0 (no) Vaksiner
WO2004076644A3 (en) A composition for delivering an agent to a target cell and uses thereof
HRP20020787B1 (hr) Postupak liječenja upotrebom kompleksa ligand-imunogen
WO2008108910A3 (en) Negative genetic regulation of cancer cell renewal in synergy with notch- or numb-specific immunotherapy
WO2007084775A3 (en) Compositions and methods for modulation of suppressor t cell activation
AR026059A1 (es) Virus de plantas modificadas y metodos para su uso
SG146643A1 (en) Treating or preventing restless legs syndrome using prodrugs of gaba analogs
CR20110172A (es) Composiciones antimicrobianas
NO20070854L (no) Humane monoklonale antistoffer mot humant IL-4.
WO2010129339A3 (en) Compositions and methods for enhancing antigen-specific immune responses
WO2006042149A3 (en) Determining and reducing immunoresistance to botulinum toxin therapy using botulinum toxin a peptides
EA200600778A1 (ru) 1,3-диметилбутилкарбоксанилиды для борьбы с нежелательными микроорганизмами
DK1482795T3 (da) Nye immuneffektor-forbindelser
WO2002058535A3 (en) Use of combretastatin a4 and its prodrugs as an immune enhancing therapy
DK1183037T3 (da) Sammensætninger til modulering af immunrespons og til behandling af inflammatoriske sygdomme
DE60320800D1 (de) Verwendung von saatmehl als bodenpestizid
UA89800C2 (en) Acylated nonadepsipeptides used as lysobactin derivatives
WO2000057908A3 (en) Attenuated dengue-1 virus vaccine
GT200600512A (es) Enzimas para reducir el estres inmunologico

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees